Literature DB >> 16736204

Danish version of the Oswestry Disability Index for patients with low back pain. Part 1: Cross-cultural adaptation, reliability and validity in two different populations.

Henrik Hein Lauridsen1, Jan Hartvigsen, Claus Manniche, Lars Korsholm, Niels Grunnet-Nilsson.   

Abstract

Over the past 10 years, a plethora of back-specific patient-orientated outcome measures have appeared in the literature. Standardisation has been advocated by an expert panel of researchers proposing a core set of instruments. Of the condition-specific questionnaires the Oswestry Disability Index (ODI) is recommended for use with low back pain (LBP) patients. To date, no Danish version of the ODI exists which has been cross-culturally adapted, validated and published in the peer-reviewed literature. A cross-cultural adaptation and validation of the ODI for the Danish language was carried out according to established guidelines: 233 patients [half of the patients were seen in the primary sector (PrS) and half in the secondary sector (SeS) of the Danish health care system] with LBP and/or leg pain completed a questionnaire booklet at baseline, 1 day or 1 week and 8 weeks follow-up. The booklet contained the Danish version of the ODI, along with the Roland Morris Disability Questionnaire, the LBP Rating Scale, the SF36 (physical function and bodily pain scales) and a global pain rating. For the ODI test-retest analysis (93 stable patients) resulted in an intraclass correlation coefficient of 0.91, a mean difference of 0.8 and 95% limits of agreements of - 11.5 to + 13. Thus, a worsening greater than 12 points and improvement greater than 13 points can be considered a "real" change above the measurement error. A substantial floor effect was found in PrS patients (14.1%). The ODI showed satisfactory cross-sectional discriminant validity when compared to the external measures. Concurrent validity of the ODI revealed: (a) a 10% and 21% lower ODI score compared to the disability and pain measures, respectively, (b) a poorer differentiation of patient disabilities and (c) an acceptable individual ODI score level compared to the external measures. Longitudinal external construct validity showed moderate correlations (range 0.56-0.78). We conclude that the Danish version of the ODI is both a valid and reliable outcome instrument in two LBP patient populations. The ODI is probably most appropriate for use in SeS patients.

Entities:  

Mesh:

Year:  2006        PMID: 16736204     DOI: 10.1007/s00586-006-0117-9

Source DB:  PubMed          Journal:  Eur Spine J        ISSN: 0940-6719            Impact factor:   3.134


  52 in total

Review 1.  A review of generic health status measures in patients with low back pain.

Authors:  J Lurie
Journal:  Spine (Phila Pa 1976)       Date:  2000-12-15       Impact factor: 3.468

Review 2.  Applying the right statistics: analyses of measurement studies.

Authors:  J M Bland; D G Altman
Journal:  Ultrasound Obstet Gynecol       Date:  2003-07       Impact factor: 7.299

Review 3.  Condition-specific outcome measures for low back pain. Part I: validation.

Authors:  U Müller; M S Duetz; C Roeder; C G Greenough
Journal:  Eur Spine J       Date:  2004-03-17       Impact factor: 3.134

4.  Tests of data quality, scaling assumptions, and reliability of the Danish SF-36.

Authors:  J B Bjorner; M T Damsgaard; T Watt; M Groenvold
Journal:  J Clin Epidemiol       Date:  1998-11       Impact factor: 6.437

5.  Reproducibility and responsiveness of health status measures. Statistics and strategies for evaluation.

Authors:  R A Deyo; P Diehr; D L Patrick
Journal:  Control Clin Trials       Date:  1991-08

6.  Capturing the patient's view of change as a clinical outcome measure.

Authors:  D Fischer; A L Stewart; D A Bloch; K Lorig; D Laurent; H Holman
Journal:  JAMA       Date:  1999 Sep 22-29       Impact factor: 56.272

Review 7.  Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines.

Authors:  F Guillemin; C Bombardier; D Beaton
Journal:  J Clin Epidemiol       Date:  1993-12       Impact factor: 6.437

Review 8.  Measuring health-related quality of life.

Authors:  G H Guyatt; D H Feeny; D L Patrick
Journal:  Ann Intern Med       Date:  1993-04-15       Impact factor: 25.391

9.  Clinical course and prognostic factors in acute low back pain: an inception cohort study in primary care practice.

Authors:  J Coste; G Delecoeuillerie; A Cohen de Lara; J M Le Parc; J B Paolaggi
Journal:  BMJ       Date:  1994-02-26

10.  The Quebec Back Pain Disability Scale. Measurement properties.

Authors:  J A Kopec; J M Esdaile; M Abrahamowicz; L Abenhaim; S Wood-Dauphinee; D L Lamping; J I Williams
Journal:  Spine (Phila Pa 1976)       Date:  1995-02-01       Impact factor: 3.468

View more
  32 in total

1.  Validation of the Croatian version of the Oswestry Disability Index.

Authors:  Ivan Domazet; Jakob Nemir; Petra Barl; Krešimir Saša Đurić; Ivan Pašalić; Hrvoje Barić; Marin Stančić
Journal:  Eur Spine J       Date:  2018-09-08       Impact factor: 3.134

2.  Danish version of the Oswestry disability index for patients with low back pain. Part 2: Sensitivity, specificity and clinically significant improvement in two low back pain populations.

Authors:  Henrik Hein Lauridsen; Jan Hartvigsen; Claus Manniche; Lars Korsholm; Niels Grunnet-Nilsson
Journal:  Eur Spine J       Date:  2006-05-31       Impact factor: 3.134

3.  Cross-cultural adaptation and validation of the Polish version of the core outcome measures index for low back pain.

Authors:  Grzegorz Miekisiak; Marta Kollataj; Jan Dobrogowski; Wojciech Kloc; Witold Libionka; Mariusz Banach; Dariusz Latka; Tomasz Sobolewski; Adam Sulewski; Andrzej Nowakowski; Grzegorz Kiwic; Adam Pala; Tomasz Potaczek
Journal:  Eur Spine J       Date:  2012-12-12       Impact factor: 3.134

4.  Cross-cultural adaptation and psychometric validation of the Indonesian version of the Oswestry Disability Index.

Authors:  Phedy Phedy; Yoshi Pratama Djaja; Singkat Dohar Apul Lumban Tobing; Luthfi Gatam; Didik Librianto; Asrafi Rizki Gatam; Nicko Perdana Hardiansyah
Journal:  Eur Spine J       Date:  2021-01-02       Impact factor: 3.134

5.  Translation and discriminative validation of the STarT Back Screening Tool into Danish.

Authors:  Lars Morsø; Hanne Albert; Peter Kent; Claus Manniche; Jonathan Hill
Journal:  Eur Spine J       Date:  2011-07-19       Impact factor: 3.134

6.  Leg pain and psychological variables predict outcome 2-3 years after lumbar fusion surgery.

Authors:  Allan D Abbott; Raija Tyni-Lenné; Rune Hedlund
Journal:  Eur Spine J       Date:  2011-02-11       Impact factor: 3.134

7.  Reliability and validity study on the Hungarian versions of the oswestry disability index and the Quebec back pain disability scale.

Authors:  Tamás Valasek; Peter Paul Varga; Zsolt Szövérfi; Michelle Kümin; Jeremy Fairbank; Aron Lazary
Journal:  Eur Spine J       Date:  2013-01-16       Impact factor: 3.134

8.  Occupational advice to help people return to work following lower limb arthroplasty: the OPAL intervention mapping study.

Authors:  Paul Baker; Carol Coole; Avril Drummond; Sayeed Khan; Catriona McDaid; Catherine Hewitt; Lucksy Kottam; Sarah Ronaldson; Elizabeth Coleman; David A McDonald; Fiona Nouri; Melanie Narayanasamy; Iain McNamara; Judith Fitch; Louise Thomson; Gerry Richardson; Amar Rangan
Journal:  Health Technol Assess       Date:  2020-09       Impact factor: 4.014

9.  What is an acceptable outcome of treatment before it begins? Methodological considerations and implications for patients with chronic low back pain.

Authors:  Henrik Hein Lauridsen; Claus Manniche; Lars Korsholm; Niels Grunnet-Nilsson; Jan Hartvigsen
Journal:  Eur Spine J       Date:  2009-06-23       Impact factor: 3.134

10.  Coordinated and tailored work rehabilitation: a randomized controlled trial with economic evaluation undertaken with workers on sick leave due to musculoskeletal disorders.

Authors:  Ute Bültmann; David Sherson; Jens Olsen; Carl Lysbeck Hansen; Thomas Lund; Jørgen Kilsgaard
Journal:  J Occup Rehabil       Date:  2009-01-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.